Back

Treatment strategies to manage hyperkalemia and control potassium levels.

1 May 2017 (13:05 - 13:20)
Organised by:
Congress Presentation Part of: Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels Miscellaneous HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

5 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Presentation thumbnail
RAASi therapy benefit and challenges in cardio-renal patients.
Professor L. Lund (Stockholm, SE)
Presentation thumbnail
Changing the treatment paradigm of hyperkalemia management to enable and optimize RAASi therapy.
Professor J. Butler (Dallas, US)
Presentation thumbnail
Panel discussion.
Professor B. Pitt (Ann Arbor, US)
Presentation thumbnail
Summary and conclusions.
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Access the full session

Session thumbnail
Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 13:05 CET
You may be interested in
thumbnail
Congress Presentation
Challenges of managing hyperkalaemia in HF patients with CKD while maintaining RAAS inhibitor therapy
31 August 2024
thumbnail
Congress Presentation
What is the treatment and management for patients with hypokalaemia? A critical review of the literature
13 June 2025
thumbnail
Webinar
Highlights from the ESC Heart and Stroke Conference
14 October 2020
thumbnail
Congress Presentation
Audience Q&A 
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources